| 000 | 01724cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030406.0 | ||
| 008 | 110503s2011 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.07.M.Sc.2011.Fa.R | ||
| 100 | 0 | _aFatma Elzahraa Ahmed Hussien Hanafy | |
| 245 | 1 | 0 |
_aRole of resistin in chronic kidney disease / _cFatma Elzahraa Ahmed Hussien Hanafy ; Supervised Hazem Elsayed Abouyoussef , Marianne fathy ishak , Shams Mohamed Kholoussi |
| 246 | 1 | 5 | _aدور الرسيستين فى امراض الكلى المومنة |
| 260 |
_aCairo : _bFatma Elzahraa Ahmed Hussien Hanafy , _c2011 |
||
| 300 |
_a140P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology | ||
| 520 | _a The physiological role and pathophysiologic importance of resistin in humans are unclear . It was firstly proposed to be involved in insulin resistance and type 2 diabetes . Resistin was found to interact with and reienforce inflammatory pathways . C- reactive protein, a marker of inflammation, was reported to be positively correlated with resistin levels in several pathophsiological conditions | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aChronic kidney disease | |
| 653 | 4 | _aInsulin resistance | |
| 653 | 4 | _aResistin | |
| 700 | 0 |
_aHazem Elsayed Abouyoussef , _eSupervisor |
|
| 700 | 0 |
_aMarianne fathy ishak , _eSupervisor |
|
| 700 | 0 |
_aShams Mohamed Kholoussi , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c33742 _d33742 |
||